Dr. Matei is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
303 E Superior Lurie 4-107
Chicago, IL 60610Phone+1 312-503-4853- Is this information wrong?
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1997 - 1999- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1993 - 1996
Carol Davila University of Medicine and PharmacyClass of 1992
Certifications & Licensure
CA State Medical License 1996 - Present
IL State Medical License 2015 - 2026
IN State Medical License 2002 - 2017- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer Start of enrollment: 2004 Oct 01
- Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer Start of enrollment: 2003 Dec 01
- Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer Start of enrollment: 2006 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer.Yinu Wang, Xiaolei Situ, Horacio Cardenas, Ellie Siu, Sayedabdulrazzaq A Alhunayan, Russell Keathley, Edward Tanner, Jian-Jun Wei, Yuying Tan, Chinmayee Vallabh Prabhu...> ;Clinical Cancer Research. 2024 Mar 15
- Nanoparticle Targeting in Chemo-Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance.Yinu Wang, Andrea E Calvert, Horacio Cardenas, Jonathon S Rink, Dominik Nahotko, Wenan Qiang, C Estelle Ndukwe, Fukai Chen, Russell Keathley, Yaqi Zhang, Ji-Xin Cheng,...> ;Advanced Science. 2024 Apr 1
- E2F1 mediates competition, proliferation and response to cisplatin in cohabitating resistant and sensitive ovarian cancer cells.Valdivia, A., Cardenas, H., Isac, A., Zhao, G., Huang, H., Cowan, M., Matei, D.> ;Frontiers in Oncology. 2024 Jan 1
- Join now to see all
Journal Articles
- Epigenetic Targeting of Ovarian Cancer Stem Cells6) Wang Y, Cardenas H, Fang F, Condello S, Taverna P, Segar M, Liu Y, Nephew KP, Matei D, Cancer Research, 7/2014
Press Mentions
Remember When Princess Diana Raised Money for Northwestern Cancer Center?February 5th, 2021
ZIP4 Is a Novel Cancer Stem Cell Marker in High-Grade Serous Ovarian CancerDecember 9th, 2020
Northwestern Scientists Awarded Top Honors for Achievement in Clinical ResearchApril 15th, 2020- Join now to see all
Grant Support
- Role Of Tissue Transglutaminase In Ovarian CancerVeterans Affairs2011–2012
- Transglutaminase Modulated Tumor-Stroma Interaction In Pancreatic CancerNational Cancer Institute2011
- A Low-Dose Decitabine Strategy For Restoring Ovarian Cancer SensitivityNational Cancer Institute2008–2009
- A Phase I Trial Of Lapatinib In Combination With Carboplatin In Patients With PLNational Center For Research Resources2007–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
